Supplementary Figure S8. Number of copies of ctHPV DNA at different timepoints for all patients (n = 4) with at least one ctHPV DNA–positive sample during early- or late follow-up but no verified relapse.
No takes yet. Share an insight, caveat, or question.
Sivars et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: